vs

Side-by-side financial comparison of Iron Mountain (IRM) and Solventum (SOLV). Click either name above to swap in a different company.

Solventum is the larger business by last-quarter revenue ($2.0B vs $1.8B, roughly 1.1× Iron Mountain). Iron Mountain runs the higher net margin — 5.1% vs 0.6%, a 4.4% gap on every dollar of revenue. On growth, Iron Mountain posted the faster year-over-year revenue change (16.6% vs -3.0%). Iron Mountain produced more free cash flow last quarter ($-16.2M vs $-273.0M). Over the past eight quarters, Iron Mountain's revenue compounded faster (11.7% CAGR vs -1.8%).

Iron Mountain Inc. is an American enterprise information management services company founded in 1951 and headquartered in Portsmouth, New Hampshire. Its records management, information destruction, and data backup and recovery services are supplied to more than 220,000 customers in 58 countries throughout North America, Europe, Latin America, Africa, Asia, and Oceania.

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

IRM vs SOLV — Head-to-Head

Bigger by revenue
SOLV
SOLV
1.1× larger
SOLV
$2.0B
$1.8B
IRM
Growing faster (revenue YoY)
IRM
IRM
+19.6% gap
IRM
16.6%
-3.0%
SOLV
Higher net margin
IRM
IRM
4.4% more per $
IRM
5.1%
0.6%
SOLV
More free cash flow
IRM
IRM
$256.8M more FCF
IRM
$-16.2M
$-273.0M
SOLV
Faster 2-yr revenue CAGR
IRM
IRM
Annualised
IRM
11.7%
-1.8%
SOLV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRM
IRM
SOLV
SOLV
Revenue
$1.8B
$2.0B
Net Profit
$93.1M
$13.0M
Gross Margin
54.7%
Operating Margin
18.5%
4.0%
Net Margin
5.1%
0.6%
Revenue YoY
16.6%
-3.0%
Net Profit YoY
-11.9%
EPS (diluted)
$0.31
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRM
IRM
SOLV
SOLV
Q1 26
$2.0B
Q4 25
$1.8B
$2.0B
Q3 25
$1.8B
$2.1B
Q2 25
$1.7B
$2.2B
Q1 25
$1.6B
$2.1B
Q4 24
$1.6B
$2.1B
Q3 24
$1.6B
$2.1B
Q2 24
$1.5B
$2.1B
Net Profit
IRM
IRM
SOLV
SOLV
Q1 26
$13.0M
Q4 25
$93.1M
$63.0M
Q3 25
$86.2M
$1.3B
Q2 25
$-43.3M
$90.0M
Q1 25
$16.2M
$137.0M
Q4 24
$105.7M
$31.0M
Q3 24
$-33.7M
$122.0M
Q2 24
$34.6M
$89.0M
Gross Margin
IRM
IRM
SOLV
SOLV
Q1 26
54.7%
Q4 25
51.4%
Q3 25
54.2%
Q2 25
54.4%
Q1 25
53.8%
Q4 24
53.9%
Q3 24
56.0%
Q2 24
54.6%
Operating Margin
IRM
IRM
SOLV
SOLV
Q1 26
4.0%
Q4 25
18.5%
6.3%
Q3 25
17.6%
80.6%
Q2 25
15.2%
9.9%
Q1 25
16.0%
7.3%
Q4 24
17.9%
6.6%
Q3 24
16.1%
13.2%
Q2 24
15.0%
11.7%
Net Margin
IRM
IRM
SOLV
SOLV
Q1 26
0.6%
Q4 25
5.1%
3.2%
Q3 25
4.9%
60.4%
Q2 25
-2.5%
4.2%
Q1 25
1.0%
6.6%
Q4 24
6.7%
1.5%
Q3 24
-2.2%
5.9%
Q2 24
2.3%
4.3%
EPS (diluted)
IRM
IRM
SOLV
SOLV
Q1 26
$0.07
Q4 25
$0.31
$0.37
Q3 25
$0.28
$7.22
Q2 25
$-0.15
$0.51
Q1 25
$0.05
$0.78
Q4 24
$0.35
$0.18
Q3 24
$-0.11
$0.70
Q2 24
$0.12
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRM
IRM
SOLV
SOLV
Cash + ST InvestmentsLiquidity on hand
$158.5M
$561.0M
Total DebtLower is stronger
$16.2B
$4.6B
Stockholders' EquityBook value
$-981.0M
$5.0B
Total Assets
$21.1B
$14.1B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRM
IRM
SOLV
SOLV
Q1 26
$561.0M
Q4 25
$158.5M
$878.0M
Q3 25
$1.6B
Q2 25
$492.0M
Q1 25
$534.0M
Q4 24
$155.7M
$762.0M
Q3 24
$772.0M
Q2 24
$897.0M
Total Debt
IRM
IRM
SOLV
SOLV
Q1 26
$4.6B
Q4 25
$16.2B
$5.0B
Q3 25
$15.5B
$5.1B
Q2 25
$14.8B
$7.8B
Q1 25
$14.2B
$7.9B
Q4 24
$13.0B
$8.0B
Q3 24
$13.2B
$8.1B
Q2 24
$12.8B
$8.3B
Stockholders' Equity
IRM
IRM
SOLV
SOLV
Q1 26
$5.0B
Q4 25
$-981.0M
$5.0B
Q3 25
$-882.0M
$5.0B
Q2 25
$-767.4M
$3.6B
Q1 25
$-698.5M
$3.3B
Q4 24
$-503.1M
$3.0B
Q3 24
$-259.0M
$3.2B
Q2 24
$-132.9M
$2.9B
Total Assets
IRM
IRM
SOLV
SOLV
Q1 26
$14.1B
Q4 25
$21.1B
$14.3B
Q3 25
$20.6B
$14.0B
Q2 25
$20.2B
$15.1B
Q1 25
$19.4B
$14.5B
Q4 24
$18.7B
$14.5B
Q3 24
$18.5B
$14.7B
Q2 24
$18.0B
$14.6B
Debt / Equity
IRM
IRM
SOLV
SOLV
Q1 26
0.92×
Q4 25
1.00×
Q3 25
1.03×
Q2 25
2.14×
Q1 25
2.43×
Q4 24
2.71×
Q3 24
2.54×
Q2 24
2.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRM
IRM
SOLV
SOLV
Operating Cash FlowLast quarter
$500.0M
Free Cash FlowOCF − Capex
$-16.2M
$-273.0M
FCF MarginFCF / Revenue
-0.9%
-13.6%
Capex IntensityCapex / Revenue
28.0%
Cash ConversionOCF / Net Profit
5.37×
TTM Free Cash FlowTrailing 4 quarters
$-931.6M
$-203.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRM
IRM
SOLV
SOLV
Q1 26
Q4 25
$500.0M
$95.0M
Q3 25
$267.6M
$76.0M
Q2 25
$375.1M
$169.0M
Q1 25
$197.3M
$29.0M
Q4 24
$431.6M
$219.0M
Q3 24
$252.9M
$169.0M
Q2 24
$382.2M
$355.0M
Free Cash Flow
IRM
IRM
SOLV
SOLV
Q1 26
$-273.0M
Q4 25
$-16.2M
$32.0M
Q3 25
$-256.3M
$-21.0M
Q2 25
$-181.6M
$59.0M
Q1 25
$-477.5M
$-80.0M
Q4 24
$-186.0M
$92.0M
Q3 24
$-143.2M
$76.0M
Q2 24
$-14.6M
$297.0M
FCF Margin
IRM
IRM
SOLV
SOLV
Q1 26
-13.6%
Q4 25
-0.9%
1.6%
Q3 25
-14.6%
-1.0%
Q2 25
-10.6%
2.7%
Q1 25
-30.0%
-3.9%
Q4 24
-11.8%
4.4%
Q3 24
-9.2%
3.7%
Q2 24
-1.0%
14.3%
Capex Intensity
IRM
IRM
SOLV
SOLV
Q1 26
Q4 25
28.0%
3.2%
Q3 25
29.9%
4.6%
Q2 25
32.5%
5.1%
Q1 25
42.4%
5.3%
Q4 24
39.1%
6.1%
Q3 24
25.4%
4.5%
Q2 24
25.9%
2.8%
Cash Conversion
IRM
IRM
SOLV
SOLV
Q1 26
Q4 25
5.37×
1.51×
Q3 25
3.10×
0.06×
Q2 25
1.88×
Q1 25
12.15×
0.21×
Q4 24
4.08×
7.06×
Q3 24
1.39×
Q2 24
11.04×
3.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRM
IRM

Storage Rental$1.1B58%
Services$781.9M42%

SOLV
SOLV

Infection Prevention and Surgical Solutions$737.0M37%
Advanced Wound Care$497.0M25%
Dental Solutions$354.0M18%
Health Information Systems$342.0M17%
All Other 4$76.0M4%

Related Comparisons